NCT02327468: Inovio TRT-001: Telomerase DNA Immunotherapy in Breast, Lung, and Pancreatic Cancers |
|
|
| Recruiting | 1 | 54 | US | INO-1400, hTERT, INO-9012, IL-12 | Inovio Pharmaceuticals, Abramson Cancer Center of the University of Pennsylvania, University of North Carolina, Thomas Jefferson University, Wayne State University | Breast Cancer, Lung Cancer, Pancreatic Cancer, Head and Neck Squamous Cell Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Esophageal Cancer, Hepatocellular Cancer | 12/17 | 04/18 | | |
NCT02960594: hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse |
|
|
| Completed | 1 | 93 | US | INO-1400, hTERT, INO-9012, IL-12, INO-1401, SynCon TERT | Inovio Pharmaceuticals, University of Pennsylvania, University of North Carolina, Thomas Jefferson University, University of Pittsburgh, Barbara Ann Karmanos Cancer Institute, Mayo Clinic | Breast Cancer, Lung Cancer, Pancreatic Cancer, Head and Neck Cancer, Ovarian Cancer, ColoRectal Cancer, Gastric Cancer, Esophageal Cancer, HepatoCellular Carcinoma | 11/18 | 11/18 | | |